Oklahoma City, Oklahoma

Oklahoma City (OKC) has emerged as a high-growth life sciences ecosystem, characterized by a unique synergy between biopharmaceutical manufacturing, clinical research and academic excellence.

At the heart of this "dark horse of innovation" is the OKC Innovation District, a 1.3-square-mile hub designed to bridge the "valley of death" by accelerating the commercialization of biotechnology breakthroughs. The region is internationally recognized for its biomanufacturing prowess, which provides critical infrastructure for therapeutic proteins and drug development.

The academic backbone of the city is the University of Oklahoma Health Sciences Center (OUHSC), which partners with the Oklahoma Medical Research Foundation (OMRF) to drive pioneering research in genomics, immunology and aging-related diseases.

OKC is particularly well-known for its healthcare innovation in specialized fields, housing the Stephenson Cancer Center (the state's only NCI-Designated Cancer Center) and the Harold Hamm Diabetes Center. With over $200 million in sponsored research funding annually, the ecosystem excels in translational research, moving discoveries from "bench to bedside" through robust Phase I clinical trial programs.

Strategic investments, such as the $35 million Build Back Better Regional Challenge grant, have solidified the city's role in the global biopharmaceutical supply chain, particularly in drug discovery and medical device development.

This collaborative environment is supported by Life Science Oklahoma, ensuring a steady pipeline of STEM workforce talent and a business-friendly climate for biotech startups.